A client has known lung cancer and has been admitted for abdominal pain and jaundice. A computed tomography (CT) scan reveals tumors in the client's liver
The client is distraught and says, "So now I have liver cancer too?" Which response by the nurse is most appropriate? a. "Yes, liver cancer is common in people who already have lung cancer."
b. "Yes, your chemotherapy left you vul-nerable to a virus that causes liver cancer."
c. "No, the tumors are actually from your lung cancer, which has metastasized."
d. "No, having tumors in two different or-gans is rare; you probably have hepatitis."
C
When a cancer metastasizes to another organ, it is still the same cancer from the original spot. This client has lung cancer that has metastasized to the liver.
You might also like to view...
The nurse suspects that the patient is experiencing a drug toxicity rather than a side effect. Which question will the nurse ask to help confirm this suspicion?
a. "When did you take your last dose of the medication?" b. "Have you been taking extra doses of the medication?" c. "Are you taking any other medications?" d. "Have you ever taken this medication in the past? "
The nurse is providing educational material for clients at the clinic. The nurse should instruct the clients to decrease weight to increase:
1. the amount of sodium in the body. 2. the amount of water in the body. 3. the imbalance of electrolytes. 4. the body temperature.
When a qualitative researcher selects, focuses, simplifies, and transforms data from field notes and/or transcripts, this is known as
a. data saturation. b. data reduction. c. data manipulation. d. coding.
Martha, a patient suffering from hypothyroidism, has just found out that she is pregnant. She contacts Dr. Hudson to find out whether she should continue her thyroid hormone replacement therapy during her pregnancy. Which of the following instructions is Dr. Hudson most likely to give Martha?
A. Discontinue treatment because the thyroid hormones administered to pregnant women readily cross the placental barrier and affect fetal development. B. Discontinue treatment until the third trimester, when there is no longer a risk of the drug affecting fetal development. C. Continue the treatment at half the dosage as the growing fetus may be very sensitive to the effects of the drug. D. Continue treatment as usual because the thyroid hormones administered to pregnant women do not readily cross the placental barrier to affect fetal development.